BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Statistics

Total Valuation

BVMF:B1ME34 has a market cap or net worth of BRL 194.09 billion. The enterprise value is 184.90 billion.

Market Cap	194.09B
Enterprise Value	184.90B

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.33%
Shares Change (QoQ)	+1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	67.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	76.07
PS Ratio	7.81
PB Ratio	9.45
P/TBV Ratio	9.61
P/FCF Ratio	145.48
P/OCF Ratio	62.36
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-191.03
EV / Sales	7.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	138.60

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.27.

Current Ratio	1.95
Quick Ratio	1.65
Debt / Equity	0.27
Debt / EBITDA	8.77
Debt / FCF	4.19
Interest Coverage	-4.70

Financial Efficiency

Return on equity (ROE) is -4.98% and return on invested capital (ROIC) is -1.37%.

Return on Equity (ROE)	-4.98%
Return on Assets (ROA)	-1.06%
Return on Invested Capital (ROIC)	-1.37%
Return on Capital Employed (ROCE)	-2.48%
Revenue Per Employee	2.26M
Profits Per Employee	-87,994
Employee Count	11,000
Asset Turnover	0.76
Inventory Turnover	1.59

Taxes

In the past 12 months, BVMF:B1ME34 has paid 623.53 million in taxes.

Income Tax	623.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+60.36%
50-Day Moving Average	64.67
200-Day Moving Average	55.96
Relative Strength Index (RSI)	75.51
Average Volume (20 Days)	30

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.87

Income Statement

In the last 12 months, BVMF:B1ME34 had revenue of BRL 24.86 billion and -967.93 million in losses. Loss per share was -9.06.

Revenue	24.86B
Gross Profit	20.76B
Operating Income	-553.13M
Pretax Income	-344.40M
Net Income	-967.93M
EBITDA	431.28M
EBIT	-553.13M
Loss Per Share	-9.06

Balance Sheet

The company has 15.02 billion in cash and 5.59 billion in debt, giving a net cash position of 9.43 billion.

Cash & Cash Equivalents	15.02B
Total Debt	5.59B
Net Cash	9.43B
Net Cash Per Share	n/a
Equity (Book Value)	20.54B
Book Value Per Share	187.00
Working Capital	11.44B

Cash Flow

In the last 12 months, operating cash flow was 3.11 billion and capital expenditures -1.78 billion, giving a free cash flow of 1.33 billion.

Operating Cash Flow	3.11B
Capital Expenditures	-1.78B
Free Cash Flow	1.33B
FCF Per Share	n/a

Margins

Gross margin is 83.51%, with operating and profit margins of -2.23% and -3.89%.

Gross Margin	83.51%
Operating Margin	-2.23%
Pretax Margin	-1.39%
Profit Margin	-3.89%
EBITDA Margin	1.74%
EBIT Margin	-2.23%
FCF Margin	5.37%

Dividends & Yields

BVMF:B1ME34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.33%
Shareholder Yield	n/a
Earnings Yield	-0.50%
FCF Yield	0.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:B1ME34 has an Altman Z-Score of 4.66 and a Piotroski F-Score of 5.

Altman Z-Score	4.66
Piotroski F-Score	5